Related Experiment Video
Updated: Jul 28, 2026
08:32
Adapting Human Videofluoroscopic Swallow Study Methods to Detect and Characterize Dysphagia in Murine Disease Models
Published on: March 1, 2015
22.3K
[Medication-induced dysphagia : A review]
C Schwemmle1, M Jungheim, S Miller
1HNO-Klinik, Arbeitsbereich Phoniatrie, Pädaudiologie, klinische Audiologie, Otto-von-Guericke-Universität Magdeburg, Leipziger Str. 44, 39120, Magdeburg, Deutschland, cornelia.schwemmle@med.ovgu.de.
HNO
|July 8, 2015
Summary
Medication can significantly impact swallowing function, leading to dysphagia, especially in older adults with polypharmacy. Reviewing and adjusting medications is crucial for managing this often-overlooked condition.
Area of Science:
- Gerontology
- Pharmacology
- Medicine
Context:
- Swallowing (deglutition) is a complex physiological process.
- Dysphagia, or swallowing difficulties, can arise from various factors including anatomical changes, surgery, and neuromuscular disorders.
- Age-related changes (presbyphagia) and polypharmacy can exacerbate swallowing issues.
Purpose:
- To highlight the underrecognized impact of medications on swallowing function.
- To emphasize the prevalence of medication-induced dysphagia, particularly in elderly patients.
- To review drug classes with direct or indirect negative effects on swallowing.
Summary:
- Medication-associated dysphagia is frequently overlooked, despite numerous drugs potentially impairing swallowing.
- Polypharmacy in older adults increases the risk of drug interactions affecting deglutition.
- Management involves medication review, dose adjustment, administration guidance, and therapeutic interventions like swallowing training.
Impact:
- Increases awareness among healthcare professionals about medication-induced dysphagia.
- Promotes critical evaluation of medication regimens in patients with swallowing difficulties.
- Encourages proactive management strategies to improve patient outcomes and quality of life.
Related Concept Videos
01:28Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
01:23Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
01:29Gastroesophageal Reflux Disease II: Clinical Features and Management
Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
01:26Esophageal Strictures-II: Clinical Features and Management
Patients with esophageal strictures often experience a range of symptoms. Initially, they may have difficulty swallowing solid foods, which can progress to include liquids. Additional symptoms may involve chest pain or discomfort, regurgitating food and fluids, heartburn, unintentional weight loss, coughing or choking during meals, and hoarseness.
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
01:26Peptic Ulcer Disease IV: Management
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
01:27Esophageal Achalasia
Esophageal achalasia is a chronic neurogenic disorder characterized by impaired relaxation of the lower esophageal sphincter (LES) and absent or ineffective peristalsis in the distal esophagus. This leads to a functional obstruction without a physical blockage, despite significant disruption of esophageal motility.EtiologyAchalasia is caused by degeneration of the myenteric (Auerbach's) plexus, specifically the loss of inhibitory ganglion cells that produce vasoactive intestinal peptide (VIP)...